First human test: new Drug's safety checked in small group
NCT ID NCT04155567
Summary
This was a small, early-stage study to see how the body processes a new drug called TAK-123 and to check its safety. It involved 10 healthy Japanese men who received a single dose through an IV. The main goal was to gather basic information on how the drug moves through the body and if it caused any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sekino Clinical Pharmacology Clinic
Toshima-ku, Tokyo, Japan
Conditions
Explore the condition pages connected to this study.